WaveMan · Form 4
Scanlan Sean F. insider trades
> Search tickers & screens ⌘K
LIVE

Scanlan Sean F. insider trades

Scanlan Sean F. has filed 28 Form 4s with the SEC that we hold, all for Treace Medical Concepts, INC. (TMCI), as Chief Innovation Officer. Across all of them we count 0 purchases worth $0 and 16 sales worth $5.4M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 38,862 shares of Treace Medical Concepts, INC. worth $783.5K, dated 2022-01-10. The first filing on our record is dated 2021-11-12 and the latest 2026-08-12.

Treace Medical Concepts, INC. (TMCI)

Chief Innovation Officer · 28 filings · 16 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-11-10S, sale reported on Form 4440$9.8K2021-11-12
2021-11-10S, sale reported on Form 424,560$528.8K2021-11-12
2022-01-03S, sale reported on Form 41,000$20.0K2022-01-05
2022-01-04S, sale reported on Form 4500$10.0K2022-01-05
2022-01-05S, sale reported on Form 4800$16.0K2022-01-05
2022-01-10S, sale reported on Form 438,862$783.5K2022-01-12
2022-01-11S, sale reported on Form 48,838$177.8K2022-01-12
2022-02-08S, sale reported on Form 421,127$423.0K2022-02-10
2022-02-09S, sale reported on Form 43,873$78.1K2022-02-10
2022-03-02S, sale reported on Form 425,000$520.5K2022-03-04
2022-11-14S, sale reported on Form 425,000$606.8K2022-11-16
2023-01-12S, sale reported on Form 425,000$639.2K2023-01-13
2023-02-15S, sale reported on Form 425,000$542.2K2023-02-17
2023-03-09S, sale reported on Form 4505$12.3K2023-03-10
2023-05-16S, sale reported on Form 425,000$636.0K2023-05-18
2025-03-17S, sale reported on Form 450,000$398.5K2025-03-19
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1856371) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms